Latest news with #investorrelations
Yahoo
7 hours ago
- Business
- Yahoo
Formycon Invites to Conference Call on 2025 Half-year Results and Announces Participation in International Investor Conferences in the 3rd Quarter of 2025
PLANEGG-MARTINSRIED, Germany - July 30, 2025 (NEWMEDIAWIRE) - Formycon AG (FSB: FYB, Prime Standard, Formycon") plans to publish its results of the first half of the 2025 fiscal year on August 13, 2025. The Management Board will discuss the company's development, key financial figures, and provide an outlook for the course of 2025. The conference call, which will be broadcast live on the internet, will take place on Wednesday, August 13, 2025, at 3:00 PM (CEST) in English. To participate in the conference call, please register at: After registration, participants will receive a confirmation email with individual dial-in data. The presentation and audio broadcast can be accessed via the following webcast link: After a brief presentation, the Management Board will be available for analysts' questions. The conference call will be recorded and can subsequently be accessed via the Formycon website at: Formycon in Dialogue Representatives of the Management Board will participate in the following international investor conferences in the third quarter of 2025: August 28, 2025HIT Hamburg Investors' DayEnno Spillner (CFO)Hamburg September 03 05, 20252025 Wells Fargo Healthcare ConferenceEnno Spillner (CFO)Everett / Boston September 08 10, 2025H.C. Wainwright 27th Annual Global Investment ConferenceEnno Spillner (CFO)New York City September 23, 2025Berenberg & Goldman Sachs German Corporate ConferenceDr. Stefan Glombitza (CEO), Enno Spillner (CFO)Munich Additionally scheduled conference participations in 2025: November 17 20, 2025Jefferies Global Healthcare ConferenceEnno Spillner (CFO)London November 24 26, 2025Deutsche Borse Equity ForumEnno Spillner (CFO)Frankfurt Please find our current events at: About Formycon:Formycon AG (FSE: FYB) is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. With FYB201/ranibizumab and FYB202/ustekinumab, Formycon already has two biosimilars on the market in Europe and the USA. A third biosimilar, FYB203/aflibercept, has been approved by the FDA, EMA, and MHRA; FYB202 is also approved in Canada. Another four biosimilar candidates are currently in development. With its biosimilars, Formycon is making an important contribution to providing as many patients as possible with access to highly effective and affordable medicines. Formycon AG is headquartered in Munich, listed in the Prime Standard of the Frankfurt Stock Exchange: FYB / ISIN: DE000A1EWVY8 / WKN: A1EWVY and is part of the SDAX and TecDAX selection indices. Further information can be found at: About Biosimilars:Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection - including 45 blockbusters with an estimated total annual global turnover of more than 200 billion US dollars. Biosimilars are successor products to biopharmaceutical drugs for which market exclusivity has expired. They are approved in highly regulated markets such as the EU, the USA, Canada, Japan and Australia in accordance with strict regulatory procedures. Biosimilars create competition and thus give more patients access to biopharmaceutical therapies. At the same time, they reduce costs for healthcare systems. Global sales of biosimilars currently amount to around 21 billion US dollars. Analysts assume that sales could rise to over 74 billion US dollars by 2030. Contact:Sabrina MullerDirector Investor Relations & Corporate CommunicationsFormycon AGFraunhoferstr. 1582152 Planegg-MartinsriedGermany Tel.: +49 (0) 89 - 86 46 67 149Fax: + 49 (0) 89 - 86 46 67 110Mail: press release may contain forward-looking statements and information which are based on Formycon's current expectations and certain assumptions. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, performance of the company, development of the products and the estimates given here. Such known and unknown risks and uncertainties comprise, among others, the research and development, the regulatory approval process, the timing of the actions of regulatory bodies and other governmental authorities, clinical results, changes in laws and regulations, product quality, patient safety, patent litigation, contractual risks and dependencies from third parties. With respect to pipeline products, Formycon AG does not provide any representation, warranties or any other guarantees that the products will receive the necessary regulatory approvals or that they will prove to be commercially exploitable and/or successful. Formycon AG assumes no obligation to update these forward-looking statements or to correct them in case of developments which differ from those anticipated. This document neither constitutes an offer to sell nor a solicitation of an offer to buy or subscribe for securities of Formycon AG. No public offering of securities of Formycon AG will be made nor is a public offering intended. This document and the information contained therein may not be distributed in or into the United States of America, Canada, Australia, Japan or any other jurisdictions, in which such offer or such solicitation would be prohibited. This document does not constitute an offer for the sale of securities in the United States. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
7 hours ago
- Business
- Associated Press
Babcock & Wilcox Sets Second Quarter 2025 Conference Call and Webcast for Monday, August 11, 2025 at 5 p.m. ET
AKRON, Ohio--(BUSINESS WIRE)--Jul 30, 2025-- Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the 'Company') will host a conference call and webcast on Monday, August 11, 2025 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's second quarter 2025 results. A news release detailing the results is expected to be issued after the market closes on the day of the conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the dial-in number for participants in all other locations is (929) 526-1599. The conference ID for all participants is 248545. A replay of this conference call will remain accessible in the Investor Relations section of the Company's website for a limited time. About Babcock & WilcoxView source version on CONTACT: Investor Contact: B&W Investor Relations 704.625.4944 [email protected] Contact: Ryan Cornell B&W Public Relations 330.860.1345 [email protected] KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: OTHER ENERGY UTILITIES OIL/GAS ENVIRONMENT COAL ALTERNATIVE ENERGY ENERGY NUCLEAR SOURCE: Babcock & Wilcox Enterprises, Inc. Copyright Business Wire 2025. PUB: 07/30/2025 05:25 PM/DISC: 07/30/2025 05:25 PM
Yahoo
7 hours ago
- Business
- Yahoo
Babcock & Wilcox Sets Second Quarter 2025 Conference Call and Webcast for Monday, August 11, 2025 at 5 p.m. ET
AKRON, Ohio, July 30, 2025--(BUSINESS WIRE)--Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, August 11, 2025 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's second quarter 2025 results. A news release detailing the results is expected to be issued after the market closes on the day of the conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the dial-in number for participants in all other locations is (929) 526-1599. The conference ID for all participants is 248545. A replay of this conference call will remain accessible in the Investor Relations section of the Company's website for a limited time. About Babcock & Wilcox Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises, Inc. is a leader in energy and environmental products and services for power and industrial markets worldwide. Follow us on LinkedIn and learn more at View source version on Contacts Investor Contact: B&W Investor Relations704.625.4944investors@ Media Contact: Ryan CornellB&W Public Relations330.860.1345rscornell@ Sign in to access your portfolio
Yahoo
8 hours ago
- Business
- Yahoo
Topgolf Callaway Brands to Release Second Quarter 2025 Financial Results
CARLSBAD, Calif., July 30, 2025 /PRNewswire/ -- Topgolf Callaway Brands Corp. (the "Company" or "Topgolf Callaway Brands") (NYSE: MODG) announced today that it intends to release its second quarter 2025 financial results on Wednesday, August 6, 2025, after the market closes. Following the release, the Company's management team will hold a conference call to review the results and discuss the Company's business and outlook beginning at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and presentation may be accessed through the Investor Relations section of the Company's website at A replay will be available online approximately two hours after the conclusion of the event through the Company's Investor Relations website. In addition, Topgolf Callaway Brands Corp. also announced that the Company will participate in the Goldman Sachs 32nd Annual Global Retailing Conference on September 4, 2025 in New York City. A live webcast and replay will be made available through the Company's Investor relations section of the Company's website. About Topgolf Callaway BrandsTopgolf Callaway Brands Corp. (NYSE: MODG) is an unrivaled tech-enabled Modern Golf and active lifestyle company delivering leading golf equipment, apparel, and entertainment, with a portfolio of global brands including Topgolf, Callaway Golf, TravisMathew, Toptracer, Odyssey, and OGIO. "Modern Golf" is the dynamic and inclusive ecosystem that includes both on-course and off-course golf. For more information, please visit Investor ContactKatina Metzidakisinvrelations@ View original content to download multimedia: SOURCE Topgolf Callaway Brands Corp. Sign in to access your portfolio
National Post
8 hours ago
- Business
- National Post
Docebo Announces Participation in Upcoming Investor Conferences in August & September
Article content Article content TORONTO — Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced today that members of its management team will present at the following investor and software industry conferences in August and September 2025: Article content Article content August 2025: Article content Canaccord 45th Annual Growth Conference – August 13th – Boston Article content September 2025: Article content For more information about these and other events, access the events and presentations page on Docebo's investor relations website Article content Conferences that have public presentations will be webcast and available on the 'Events & Presentations' section of the Company's investor relations website. Article content About Docebo Article content Docebo (NASDAQ:DCBO; TSX:DCBO) is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo's end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business. Article content Article content Article content
